Shares in Abingdon Health PLC (AIM:ABDX) rose 14% to 8.24p after the AIM-listed rapid diagnostic test developer announced contracts worth approximately £4.8 million to develop and scale up the ...

Abingdon Health, the York-based developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, has been awarded contracts worth £4.8m for the development of lateral ...

Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...

Cases of the ‘Cicada’ Covid variant are increasing. These are the 7 symptoms you need to know, according to experts.

Abingdon Health PLC on Monday said it had won a series of contracts with a US-based customer to develop, scale up, and manufacture several lateral flow devices measuring multiple biomarkers. The York, ...

Patent strengthens competitive position in European drug screening market and reinforces Company's European intellectual property protectionNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio ...

We're born knowing how to breathe, but learning to maintain the quality of your inhalations and exhalations can improve your ...

Chinese researchers have been building a body of work on how solid rocket motors behave when ignited deep underwater, where ...

Exclusive US distributor Phase Scientific will now roll out the rapid test via an established commercial footprint and other distribution agreements.